These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
432 related items for PubMed ID: 10908893
1. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Kantarci K, Jack CR, Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC. Neurology; 2000 Jul 25; 55(2):210-7. PubMed ID: 10908893 [Abstract] [Full Text] [Related]
2. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease. Wang Z, Zhao C, Yu L, Zhou W, Li K. Acta Radiol; 2009 Apr 25; 50(3):312-9. PubMed ID: 19235582 [Abstract] [Full Text] [Related]
3. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment. Wang T, Xiao S, Li X, Ding B, Ling H, Chen K, Fang Y. Int Psychogeriatr; 2012 Jan 25; 24(1):19-27. PubMed ID: 21676281 [Abstract] [Full Text] [Related]
4. N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI). Walecki J, Barcikowska M, Ćwikła JB, Gabryelewicz T. Med Sci Monit; 2011 Dec 25; 17(12):MT105-11. PubMed ID: 22129910 [Abstract] [Full Text] [Related]
5. A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer's disease. Shinno H, Inagaki T, Miyaoka T, Okazaki S, Kawamukai T, Utani E, Inami Y, Horiguchi J. J Neurol Sci; 2007 Sep 15; 260(1-2):132-8. PubMed ID: 17540407 [Abstract] [Full Text] [Related]
13. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia. Targosz-Gajniak MG, Siuda JS, Wicher MM, Banasik TJ, Bujak MA, Augusciak-Duma AM, Opala G. J Neurol Sci; 2013 Dec 15; 335(1-2):58-63. PubMed ID: 24035276 [Abstract] [Full Text] [Related]
14. Contribution of 1H spectroscopy to a brief cognitive-functional test battery for the diagnosis of mild Alzheimer's disease. Silveira de Souza A, de Oliveira-Souza R, Moll J, Tovar-Moll F, Andreiuolo PA, Bottino CM. Dement Geriatr Cogn Disord; 2011 Dec 15; 32(5):351-61. PubMed ID: 22311276 [Abstract] [Full Text] [Related]
17. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study. Waldman AD, Rai GS. Neuroradiology; 2003 Aug 15; 45(8):507-12. PubMed ID: 12879326 [Abstract] [Full Text] [Related]
19. Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice. Waragai M, Hata S, Suzuki T, Ishii R, Fujii C, Tokuda T, Arai H, Ohrui T, Higuchi S, Yoshida M, Igarashi K, Moriya M, Iwai N, Uemura K. J Alzheimers Dis; 2014 Aug 15; 41(4):1207-22. PubMed ID: 24787913 [Abstract] [Full Text] [Related]